Quick Answer
EXELIXIS, INC. reported R&D Expense of $825.00 million for fiscal year 2025.
EXELIXIS, INC. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $825.00M | -9.4% |
| 2024 | $910.41M | -12.8% |
| 2023 | $1.04B | +17.1% |
| 2022 | $891.81M | +28.6% |
| 2021 | $693.72M | +26.6% |
| 2020 | $547.85M | +62.6% |
| 2019 | $336.96M | +84.9% |
| 2018 | $182.26M | +62.5% |
| 2017 | $112.17M | +16.9% |
| 2016 | $95.97M | -0.4% |
| 2015 | $96.35M | -49.0% |
| 2014 | $189.10M | +5.8% |
| 2013 | $178.76M | +38.7% |
| 2012 | $128.88M | -17.8% |
| 2011 | $156.84M | -25.6% |
| 2010 | $210.68M | -10.2% |
| 2009 | $234.70M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $199.16M | -10.5% | -0.6% |
| June 30, 2025 | $200.36M | -5.1% | -5.6% |
| March 31, 2025 | $212.23M | -6.8% | -4.6% |
| September 30, 2024 | $222.57M | -33.1% | +5.4% |
| June 30, 2024 | $211.15M | -9.2% | -7.3% |
| March 31, 2024 | $227.69M | -2.8% | -31.5% |
| September 30, 2023 | $332.58M | +67.3% | +43.0% |
| June 30, 2023 | $232.57M | +16.6% | -0.7% |
- EXELIXIS, INC. showed a decrease of -9.4% in R&D Expense compared to the prior fiscal year.
- Over the 2009–2025 period, EXELIXIS, INC.’s r&d expense has grown by 251.5% (from $234.70 million to $825.00 million).
- The most recent figure is from EXELIXIS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 10, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: